You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: August 13, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Nitrofurantoin patents expire, and what generic alternatives are available?

Nitrofurantoin is a drug marketed by Actavis Labs Fl Inc, Impax Labs Inc, Invatech, Mylan, Novel Labs Inc, Sun Pharm Industries, Watson Labs, Zydus Pharms, Actavis Mid Atlantic, Amneal Pharms, Nostrum Labs Inc, Elkins Sinn, Ivax Sub Teva Pharms, Sandoz, Whiteworth Town Plsn, Ranbaxy Labs Ltd, Sunny Pharmtech Inc, and Watson Labs Inc. and is included in thirty NDAs.

The generic ingredient in NITROFURANTOIN is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.

Drug patent expirations by year for NITROFURANTOIN

See drug prices for NITROFURANTOIN

Drug Sales Revenue Trends for NITROFURANTOIN

See drug sales revenues for NITROFURANTOIN

Recent Clinical Trials for NITROFURANTOIN

Identify potential brand extensions & 505(b)(2) entrants

Atlantic Health SystemPhase 4
GlaxoSmithKlinePhase 3
Washington University School of MedicinePhase 4

See all NITROFURANTOIN clinical trials

Pharmacology for NITROFURANTOIN
Medical Subject Heading (MeSH) Categories for NITROFURANTOIN

US Patents and Regulatory Information for NITROFURANTOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 076951-001 Mar 30, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz NITROFURANTOIN nitrofurantoin TABLET;ORAL 080043-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs NITROFURANTOIN MACROCRYSTALLINE nitrofurantoin, macrocrystalline CAPSULE;ORAL 070248-001 Jun 24, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.